{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:25:50Z","timestamp":1790198750230,"version":"4.1.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":1981,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Azotemia occurs in cats administered doxorubicin, but risk factors have not been explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine incidence of progressive increases in serum creatinine concentration in cats with cancer receiving doxorubicin in single or multiagent chemotherapy protocols and associated risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Seventy cats with cancer receiving doxorubicin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study (2007-2017) of cats with indices of kidney function recorded before and after doxorubicin administration was reviewed. Cats diagnosed with kidney injury because of known etiologies other than possible doxorubicin toxicosis were excluded. Variables were compared to identify risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Mean age (\u00b1SD) was 10.9\u2009years (\u00b13.2). Cancer types included lymphoma (n = 36), sarcoma (n = 19) and carcinoma (n = 14). Chronic kidney disease was present in 29\/70 (41%) cats before receiving doxorubicin. Of 70 cats, 24 (34%) developed an increase in serum creatinine concentration \u22650.3 mg\/dL and 10 (14%) had an increase \u226550% from baseline. Mean time to increases in serum creatinine concentration \u22650.3 mg\/dL from first administration of doxorubicin was 119.3\u2009days (\u00b189.7), with mean 2.8 (\u00b11.2) doses administered. Neutropenia or anemia during chemotherapy and number of radiation therapy treatments under general anesthesia were risk factors for increases in serum creatinine concentration (P\u2009&amp;lt;\u2009.05). Cats receiving single agent doxorubicin had a higher likelihood of an increase in serum creatinine concentration \u22650.3 mg\/dL from baseline than cats receiving CHOP-based chemotherapy protocols (OR 20.0, 95% CI 2.9-100).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Progressive increases in serum creatinine concentration from baseline were common in cats receiving doxorubicin and associated risk factors were identified.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.15867","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T21:56:21Z","timestamp":1597182981000},"page":"2048-2055","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Risk factors associated with progressive increases in serum creatinine concentrations in cats with cancer receiving doxorubicin"],"prefix":"10.1093","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6935-9463","authenticated-orcid":false,"given":"Lucy","family":"Kopecny","sequence":"first","affiliation":[{"name":"University of California, Davis Department of Veterinary Medicine and Epidemiology, , Davis, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1445-5113","authenticated-orcid":false,"given":"Carrie A.","family":"Palm","sequence":"additional","affiliation":[{"name":"University of California, Davis Department of Veterinary Medicine and Epidemiology, , Davis, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Skorupski","sequence":"additional","affiliation":[{"name":"University of California, Davis Department of Veterinary Surgical and Radiological Sciences, , Davis, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikel","family":"Delgado","sequence":"additional","affiliation":[{"name":"University of California, Davis Department of Veterinary Medicine and Epidemiology, , Davis, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Rebhun","sequence":"additional","affiliation":[{"name":"University of California, Davis Department of Veterinary Surgical and Radiological Sciences, , Davis, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"key":"2026020922083741900_jvim15867-bib-0001","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","article-title":"A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and daunorubicin","volume":"57","author":"Gewirtz","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"2026020922083741900_jvim15867-bib-0002","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1939-1676.1993.tb01024.x","article-title":"Systemic toxicity associated with doxorubicin administration in cats","volume":"7","author":"Okeefe","year":"1993","journal-title":"J Vet Intern Med"},{"key":"2026020922083741900_jvim15867-bib-0003","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000414793","article-title":"Application of puromycin aminonucleoside and Adriamycin to induce chronic renal failure in the rat","volume":"60","author":"Grond","year":"1988","journal-title":"Contrib Nephrol"},{"key":"2026020922083741900_jvim15867-bib-0004","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2460\/ajvr.1979.40.11.1537","article-title":"Pathologic features of Adriamycin toxicosis in young pigs \u2013 non-skeletal lesions","volume":"40","author":"Vanvleet","year":"1979","journal-title":"Am J Vet Res"},{"key":"2026020922083741900_jvim15867-bib-0005","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0041-008X(72)90149-4","article-title":"Chronic toxicity of Adriamycin: a new antineoplastic antibiotic","volume":"21","author":"Bertazzoli","year":"1972","journal-title":"Toxicol Appl Pharmacol"},{"key":"2026020922083741900_jvim15867-bib-0006","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1939-1676.2002.tb02415.x","article-title":"Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats","volume":"16","author":"Poirier","year":"2002","journal-title":"J Vet Intern Med"},{"key":"2026020922083741900_jvim15867-bib-0007","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1939-1676.1988.tb02794.x","article-title":"Efficacy and toxicity of doxorubicin and cyclophosphamide used in the treatment of selected malignant-tumors in 23 cats","volume":"2","author":"Mauldin","year":"1988","journal-title":"J Vet Intern Med"},{"key":"2026020922083741900_jvim15867-bib-0008","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jfms.2007.12.009","article-title":"A comparison of toxicity of two dosing schemes for doxorubicin in the cat","volume":"10","author":"Reiman","year":"2008","journal-title":"J Feline Med Surg"},{"key":"2026020922083741900_jvim15867-bib-0009","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ekir.2017.02.008","article-title":"Anticancer drug-induced acute kidney injury","volume":"2","author":"Izzedine","year":"2017","journal-title":"Kidney Int Rep"},{"key":"2026020922083741900_jvim15867-bib-0010","author":"International Renal Interest Society"},{"key":"2026020922083741900_jvim15867-bib-0011","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jfms.2007.02.005","article-title":"A prospective investigation of the prevalence and prognostic significance of weight loss and changes in body condition in feline cancer patients","volume":"9","author":"Baez","year":"2007","journal-title":"J Feline Med Surg"},{"key":"2026020922083741900_jvim15867-bib-0012","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/vco.283","article-title":"Common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1","volume":"14","author":"Veterinary Cooperative Oncology Group","year":"2016","journal-title":"Vet Comp Oncol"},{"key":"2026020922083741900_jvim15867-bib-0013","author":"International Renal Interest Society"},{"key":"2026020922083741900_jvim15867-bib-0014","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11259-017-9694-9","article-title":"B-mode and Doppler ultrasound of chronic kidney disease in dogs and cats","volume":"41","author":"Bragato","year":"2017","journal-title":"Vet Res Commun"},{"key":"2026020922083741900_jvim15867-bib-0015","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2460\/javma.232.5.728","article-title":"Acute intrinsic renal failure in cats: 32 cases (1997-2004)","volume":"232","author":"Worwag","year":"2008","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922083741900_jvim15867-bib-0016","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1939-1676.2010.0566.x","article-title":"Association of iatrogenic hypothyroidism with azotemia and reduced survival time in cats treated for hyperthyroidism","volume":"24","author":"Williams","year":"2010","journal-title":"J Vet Intern Med"},{"key":"2026020922083741900_jvim15867-bib-0017","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1939-1676.2010.0550.x","article-title":"Survival and the development of azotemia after treatment of hyperthyroid cats","volume":"24","author":"Williams","year":"2010","journal-title":"J Vet Intern Med"},{"key":"2026020922083741900_jvim15867-bib-0018","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/jvim.12835","article-title":"Symmetric dimethylarginine assay validation, stability, and evaluation as a marker for the early detection of chronic kidney disease in dogs","volume":"29","author":"Nabity","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020922083741900_jvim15867-bib-0019","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1681\/ASN.2008070669","article-title":"Creatinine kinetics and the definition of acute kidney injury","volume":"20","author":"Waikar","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2026020922083741900_jvim15867-bib-0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1098612X12464628","article-title":"Routine health screening findings in apparently healthy middle-aged and old cats","volume":"15","author":"Paepe","year":"2013","journal-title":"J Feline Med Surg"},{"key":"2026020922083741900_jvim15867-bib-0021","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/jvim.12445","article-title":"Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease","volume":"28","author":"Hall","year":"2014","journal-title":"J Vet Intern Med"},{"key":"2026020922083741900_jvim15867-bib-0022","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tvjl.2015.04.032","article-title":"Chemotherapy-induced neutropenia is associated with prolonged remission duration and survival time in canine lymphoma","volume":"205","author":"Wang","year":"2015","journal-title":"Vet J"},{"key":"2026020922083741900_jvim15867-bib-0023","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00280-010-1487-6","article-title":"Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy","volume":"68","author":"Shitara","year":"2011","journal-title":"Cancer Chemoth Pharm"},{"key":"2026020922083741900_jvim15867-bib-0024","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/ALN.0000000000000022","article-title":"Perioperative organ injury","volume":"119","author":"Bartels","year":"2013","journal-title":"Anesthesiology"},{"key":"2026020922083741900_jvim15867-bib-0025","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/1098612X14546920","article-title":"Routine plasma biochemistry analytes in clinically healthy cats: within-day variations and effects of a standard meal","volume":"17","author":"Reynolds","year":"2015","journal-title":"J Feline Med Surg"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.15867","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvim.15867","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvim.15867","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/34\/5\/2048\/66660990\/jvim15867.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/34\/5\/2048\/66660990\/jvim15867.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:15:54Z","timestamp":1770693354000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/34\/5\/2048\/8448350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.15867","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,9,1]]},"assertion":[{"value":"2019-12-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}